The Precision Medicine and Personalized Cancer Biomarkers Market is at the forefront of transforming cancer care by tailoring treatments to individual patients based on their unique genetic and molecular characteristics. Precision medicine is a revolutionary approach that recognizes the heterogeneity of cancer and aims to optimize therapeutic outcomes through personalized interventions. Biomarkers, essential components of precision medicine, provide valuable insights into a patient's cancer ... Read more

The cancer biomarkers market is estimated to be valued at US$ 380.84 Bn in 2023 and is expected to exhibit a CAGR of 14. % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Cancer biomarkers are biological molecules found in blood, urine, other body fluids or tissues that are indicators of normal or abnormal biological processes, pathogenic processes, or ... Read more